The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKings Arms Yard Regulatory News (KAY)

Share Price Information for Kings Arms Yard (KAY)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 19.40
Bid: 18.90
Ask: 19.90
Change: 0.00 (0.00%)
Spread: 1.00 (5.291%)
Open: 19.40
High: 19.40
Low: 19.40
Prev. Close: 19.40
KAY Live PriceLast checked at -
Kings Arms Yard VCT is an Investment Trust

To produce a regular and predictable dividend stream with an appreciation in capital value, invests in a broad portfolio of higher growth businesses across a variety of sectors of the UK economy including higher risk technology companies.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Kings Arms Yard VCT PLC: Interim Management Statement

21 May 2019 10:42



Kings Arms Yard VCT PLC: Interim Management Statement

Kings Arms Yard VCT PLC Interim Management StatementLEI Code 213800DK8H27QY3J5R45

IntroductionI am pleased to present Kings Arms Yard VCT PLC (the “Company”)’s interim management statement for the period from 1 January 2019 to 31 March 2019.

Performance and dividendsThe Company’s unaudited net asset value (NAV) as at 31 March 2019 was £70.76 million or 23.38 pence per share (excluding treasury shares), an increase of 0.60 pence per share (2.6 per cent.) since 31 December 2018.

After accounting for the dividend paid of 0.60 pence per share on 30 April 2019 to shareholders on the register on 5 April 2019, the NAV is 22.78 pence per share.

Share buy-backsDuring the period from 1 January 2019 to 31 March 2019, the Company purchased 897,000 shares for £191,000 at an average price of 21.21 pence per share. All of the shares are to be held in treasury.

It remains the Board’s policy to buy back shares in the market, subject to the overall constraint that such purchases are in the Company’s interest, including the maintenance of sufficient resources for investment in existing and new portfolio companies and the continued payment of dividends to shareholders.

It is the Board’s intention for such buy-backs to be at around a 5 per cent. discount to net asset value, so far as market conditions and liquidity permit.

Portfolio

The following investments have been made during the period from 1 January 2019 to 31 March 2019:

New investments£000sActivity
Avora Limited510Developer of software to improve decision making through augmented analytics & machine learning
Total new investments510 

Follow on investments £000sActivity
Elateral Group Limited125Provider of digital marketing software
Beddlestead Limited104Wedding venue operator
Convertr Media Limited45Digital lead generation software
Mirada Medical Limited13Developer of medical imaging software using Deep Learning
Total follow on investments287 

Top ten holdings as at 31 March 2019:

Portfolio companyCarrying value£000s% of net asset valueActivity
Active Lives Care Limited7,62110.8Owner and operator of a 75 bed care home in Cumnor Hill, Oxfordshire
Ryefield Court Care Limited5,4397.7Owner and operator of a 60 bed care home in Hillingdon, Middlesex
Proveca Limited4,6776.6Reformulation of medicines for paediatric use
Egress Software Technologies Limited4,5456.4Encrypted email & file transfer service provider
Chonais River Hydro Limited3,3764.8Owner and operator of a 2 MW hydro-power scheme in the Scottish Highlands
Antenova Limited2,7313.9Supplier of integrated antennas and RF solutions
Perpetuum Limited2,2683.2Provider of vibration harvester powered wireless sensing systems for the rail and industrial sectors
The Street by Street Solar Programme Limited1,8282.6Owns and operates photovoltaic systems on domestic properties in the UK
Quantexa Limited1,8162.6Network analytics platform to detect financial crime
Anthropics Technology Limited1,6772.4Provider of digital image enhancement software

A full breakdown of the Company’s portfolio can be found on the Company’s webpage on the Manager’s website at www.albion.capital/funds/KAY, by following the ‘Portfolio of Investments’ link under the ‘Fund reports’ section.

Material events and transactions after the period end

Portfolio

After the period end, the Company undertook the following investment transactions:

Disposal of the remaining shares in ErgoMed Plc for £1.2 million;Disposal of Earnside Energy for £950,000; Investment of £955,000 in an existing portfolio company, Proveca, which develops drugs specifically formulated for children; Investment of £262,000 in an existing portfolio company, Perpetuum, which provides vibration harvester powered wireless sensing systems for the rail and industrial sectors;Investment of £260,000 in a new portfolio company, Limitless Technology, which provides a customer service platform powered by crowd and machine learning technology;Investment of £180,000 in an existing portfolio company, OmPrompt Holdings, which provides process automation software;Investment of £145,000 in an existing portfolio company, Symetrica, a designer and manufacturer of radiation detection equipment;Investment of £125,000 in an existing portfolio company, Elateral Group, which provides digital marketing software; Investment of £91,000 in a new portfolio company, Imandra, which provides automated software testing and an enhanced learning experience for artificial neural networks; andInvestment of £27,000 in an existing portfolio company, Aridhia Informatics, a healthcare informatics and analysis provider.

Albion VCTs prospectus Top Up Offers 2018/19

The Board was delighted to announce on 5 April 2019 that the Offer pursuant to the Prospectus dated 7 January 2019 had closed having reached its £8 million limit. The proceeds of the Offer will be used to provide further resources at a time when a number of attractive investment opportunities are being seen.

The following new Ordinary shares of nominal value 1 penny per share were allotted under the Albion VCTs prospectus Top Up Offers 2018/19 after 31 March 2019:

Date of allotmentNumber of shares issuedAggregate nominal value of shares £’000Issue price per share (including costs of issue)Net proceeds £’000
1 April 201926,943,08726923.2 to 23.46,149
5 April 20195,377,5835423.41,227
12 April 20191,923,5521922.6 to 22.8428
Total 34,244,222342 7,804

There have been no further significant events or transactions that the Board is aware of which would have a material impact on the financial position of the Company between 1 April 2019 to 21 May 2019.

Further informationThe Company continues to offer a dividend reinvestment scheme to existing shareholders. Details of this Scheme can be found at www.albion.capital/funds/KAY.

Further information regarding historic and current financial performance and other useful shareholder information can be found on the Company’s webpage on the Manager’s website under www.albion.capital/funds/KAY.

Robin Field, Chairman21 May 2019

For further information please contact: Albion Capital Group LLP – Tel: 020 7601 1850


Date   Source Headline
24th Apr 20241:45 pmGNWPortfolio Company Update
19th Apr 20244:29 pmGNWKings Arms Yard VCT PLC: Annual Financial Report
16th Apr 20242:25 pmGNWIssue of Equity and Total Voting Rights
3rd Apr 20242:06 pmGNWDividend Declaration
28th Mar 20242:00 pmGNWTotal voting rights and Capital
25th Mar 20242:30 pmGNWDirector/PDMR Shareholding
25th Mar 202410:15 amGNWIssue of Equity and Total Voting Rights
19th Mar 20249:32 amGNWCLOSURE OF THE COMPANY'S OFFER
12th Mar 20243:30 pmGNWNAV announcement and Portfolio company update
29th Feb 20242:00 pmGNWTotal voting rights and Capital
31st Jan 20241:30 pmGNWTotal voting rights and Capital
29th Dec 20231:00 pmGNWTotal voting rights and Capital
19th Dec 20235:37 pmGNWTransaction in Own Shares and Total Voting Rights and Capital
15th Dec 20233:45 pmGNWPublication of Prospectus
5th Dec 202312:49 pmGNWKings Arms Yard VCT PLC: Interim Management Statement
30th Nov 20232:00 pmGNWTotal voting rights and Capital
1st Nov 20239:41 amGNWDirector/PDMR Shareholding
31st Oct 20239:48 amGNWIssue of Equity and Total Voting Rights and Capital
30th Oct 20232:00 pmGNWChange of the Company's Auditor
19th Oct 20232:54 pmGNWTransaction in Own Shares and Total Voting Rights and Capital
12th Oct 202310:30 amGNWStatement regarding the proposed issue of a prospectus
29th Sep 20232:29 pmGNWTotal voting rights and Capital
22nd Sep 202312:50 pmGNWKings Arms Yard VCT PLC: Half-yearly Financial Report
1st Sep 202311:15 amGNWDirectorate change
31st Aug 20232:00 pmGNWTotal voting rights and Capital
31st Jul 20232:14 pmGNWTotal voting rights and Capital
30th Jun 20232:10 pmGNWTotal voting rights and Capital
29th Jun 20231:50 pmGNWTransaction in Own Shares and Total Voting Rights and Capital
7th Jun 20236:52 pmGNWAGM Statement
7th Jun 202311:41 amGNWKings Arms Yard VCT PLC: Interim Management Statement
31st May 20232:00 pmGNWTotal voting rights and Capital
28th Apr 202310:23 amGNWDirector/PDMR Shareholding
28th Apr 202310:22 amGNWIssue of Equity and Total Voting Rights and Capital
19th Apr 20235:30 pmGNWTransaction in Own Shares and Total Voting Rights and Capital
19th Apr 20239:03 amGNWDirectorate Notification
14th Apr 20232:30 pmGNWIssue of Equity and Total Voting Rights and Capital
11th Apr 20234:45 pmGNWPublication of a supplementary prospectus
5th Apr 20236:04 pmGNWKings Arms Yard VCT PLC: Annual Financial Report
31st Mar 20232:30 pmGNWIssue of Equity and Total Voting Rights and Capital
29th Mar 20231:19 pmGNWDividend Declaration
16th Mar 20239:09 amGNWClosure of the Company's offer
28th Feb 20232:00 pmGNWTotal voting rights and Capital
24th Feb 20236:26 pmGNWChange of Allotment Date
23rd Feb 202312:45 pmGNWNAV Announcement
31st Jan 20232:00 pmGNWTotal voting rights and Capital
18th Jan 20233:49 pmGNWOffer Update
30th Dec 202212:00 pmGNWTotal voting rights and Capital
19th Dec 20226:06 pmGNWTransaction in Own Shares and Total Voting Rights and Capital
5th Dec 20223:45 pmGNWDirector/PDMR Shareholding
5th Dec 202212:15 pmGNWIssue of Equity and Total Voting Rights and Capital

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.